University Hospital Würzburg
Welcome,         Profile    Billing    Logout  
 49 Trials 
31 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fassnacht, Martin
Spencer, NCT04187404 / 2019-003396-19: A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Terminated
1/2
70
Europe, US
EO2401, Nivolumab
Enterome
Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma
05/24
10/24
ACHT, NCT04768127: Adipositas Care & Health Therapy

Active, not recruiting
N/A
586
Europe
early aftercare, mid-term to late aftercare
Wuerzburg University Hospital, Deutsche Stiftung für chronisch Kranke, Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie e.V. (DGAV), AOK Bayern, Kassenärztliche Vereinigung Bayern, symeda GmbH, AMC Wolfartklinik Gräfelfing, Schön Klinik Nürnberg Fürth, Dr. Lubos Kliniken Bogenhausen, Klinikum Memmingen, Klinikum Passau, Klinikum Nürnberg, Helmholtz Zentrum München
Patients After Metabolic-bariatric Surgery, Obesity, Morbid
11/22
12/24
Einsele, Hermann
NCT01685814 / 2009-016616-21: Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance

Active, not recruiting
3
406
Europe
Lenalidomide, Bortezomib, autologous stem cell transplant, allogeneic stem cell transplant
Wuerzburg University Hospital, ClinAssess GmbH, Celgene Corporation
Previously Untreated Symptomatic Multiple Myeloma
09/16
12/23
DSMM XVII, NCT03948035 / 2017-001616-11: Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

Active, not recruiting
3
576
Europe
Elotuzumab, Empliciti®, Carfilzomib, Kyprolis®, Lenalidomide, Revlimid®, Dexamethasone, Fortecortin®, autologous stem cell transplant
Wuerzburg University Hospital, ClinAssess GmbH, Arbeitsgemeinschaft medikamentoese Tumortherapie
Newly Diagnosed Multiple Myeloma
08/29
08/29
MYRIAM, NCT03308474: Myeloma Registry Platform

Recruiting
N/A
2200
Europe
Routine care as per site standard.
iOMEDICO AG, Deutsche Studiengruppe Multiples Myelom (DSMM)
Multiple Myeloma
12/26
12/28
Meybohm, Patrick
NCT02147795: The German Patient Blood Management Network

Recruiting
N/A
1000000
Europe
Johann Wolfgang Goethe University Hospital, Vifor Pharma, B. Braun Melsungen AG, CSL Behring, Fresenius Kabi
Clinical Safety of a PBM Program
12/24
12/25
Seefried, Lothar
BurGER, NCT04695860: Anti-FGF23 (Burosumab) in Adult Patients With XLH

Completed
3b
36
Europe
Burosumab
Wuerzburg University Hospital, Kyowa Kirin, Inc.
X-linked Hypophosphatemia
03/23
03/23
NCT05890794: Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Completed
1/2
12
Europe
Ilofotase Alfa, 0.8 mg/kg, recAP, Ilofotase Alfa, 3.2 mg/kg
AM-Pharma
Hypophosphatasia
07/23
07/23
IdeFIX, NCT04946409: Burden of Disease and Functional Impairment in XLH

Active, not recruiting
N/A
60
Europe
no intervention
Wuerzburg University Hospital, Kyowa Kirin, Inc.
X Linked Hypophosphatemia
03/24
10/24
Wanner, Christoph
ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy

Active, not recruiting
3
404
Europe, Canada, Japan, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo
Chinook Therapeutics, Inc.
IgA Nephropathy, Immunoglobulin A Nephropathy
12/26
12/26
Stoppe, Christian
SUSTAINCSX, NCT02002247: SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).

Active, not recruiting
3
1400
Europe, Canada
sodium selenite, selenium, Placebo, NaCl 0.9%
Daren K. Heyland, biosyn Arzneimittel GmbH, Queen's University, RWTH Aachen University
Heart Disease
02/21
07/21
MODIFYCSX, NCT06279793: Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

Recruiting
2
120
Europe
Long-chain n-3 fatty acids, Omegaven®, Intravenous 0.9% Sodium Chloride, Saline Infusion
GCP-Service International West GmbH, University Hospital, Bonn, University Hospital Muenster, University Hospital Goettingen, University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital
Cardiac Surgery, High Risk Patients, Intensive Care Unit, Cardiopulmonary Bypass, Valve Surgeries
12/24
12/25
Kranke, Peter
NCT05546359 / 2022-002947-23: Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients

Recruiting
2/3
410
Europe, Canada, US
Amisulpride Injection, Barhemsys, Dexamethasone, Decadron
Acacia Pharma Ltd, Amicus CD LLC, Premier Research Group plc
Nausea and Vomiting, Postoperative
06/25
12/25
NCT03567577 / 2017-003855-47: Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

Recruiting
2
95
Europe
Solnatide 25 mg powder for reconstitution for solution for inhalation, AP301, 0.9% Saline Solution
Apeptico Forschung und Entwicklung GmbH
ARDS
12/24
12/24
Nordbeck, Peter
NCT04840667 / 2018-004689-32: A Study of Replagal in Treatment-naïve Adults With Fabry Disease

Terminated
3
17
Europe, Canada
REPLAGAL, SHP675
Shire
Fabry Disease
12/22
12/22
STAAR, NCT04046224 / 2019-000667-24: Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease

Active, not recruiting
1/2
34
Europe, Canada, US, RoW
ST-920
Sangamo Therapeutics
Fabry Disease
04/25
09/25
NCT03022851: The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

Recruiting
N/A
30
Europe, RoW
Occlutech AFR Device
Occlutech International AB
Pulmonary Hypertension
02/23
12/23
NCT05425459: RESPONDER-HF Trial

Recruiting
N/A
750
Europe, Canada, US, RoW
Corvia Atrial Shunt System / IASD System II, Intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)
Corvia Medical
Heart Failure, Heart Failure, Diastolic
05/25
03/31
PRAETORIAN-DFT, NCT03495297: A Randomised Trial of S-ICD Implantation with and Without Defibrillation Testing

Active, not recruiting
N/A
965
Europe, US
ommitence of defibrillation testing
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Boston Scientific Corporation
Ventricular Arrythmia
04/25
07/25
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Wöckel, Achim
ADAPTcycle, NCT04055493: Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Active, not recruiting
3
1684
Europe
Ribociclib 200Mg Oral Tablet, Kisqali
West German Study Group, Novartis, Genomic Health®, Inc.
Breast Cancer Female
07/27
07/27
SMARAGD, NCT05129969: Registry Platform Ovarian and Endometrial Cancer

Recruiting
N/A
1375
Europe
Physician's choice according to patient's needs.
iOMEDICO AG
Ovarian Cancer, Endometrial Cancer, Ovary Neoplasm, Endometrial Neoplasms, Carcinoma, Ovarian, Carcinoma, Neoplasm, Ovarian
12/30
12/30
Razzouk, Louai
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Kroiss, Matthias
LIBRETTO-531, NCT04211337 / 2019-001978-28: A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Active, not recruiting
3
291
Europe, Canada, Japan, US, RoW
Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib
Loxo Oncology, Inc., Eli Lilly and Company
Medullary Thyroid Cancer
05/23
02/26
NCT03906331: Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Approved for marketing
N/A
Europe, Japan, US, RoW
Selpercatinib, LOXO-292, LY3527723
Eli Lilly and Company, Eli Lilly and Company
Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer, Breast Cancer, Pancreatic Cancer, Papillary Thyroid Cancer, Other Solid Tumors With Evidence of Activating RET Alteration
 
 
Meraj, Perwaiz
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
Rodriguez, Crystal Ann
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
Nordbeck, PD Dr Peter
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
Buravezky, Larissa
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
Chifu, Irina
No trials found
Punke, Mark
No trials found
Kortüm
No trials found

Download Options